Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Culture

Harvey Singer Caught His Prostate Cancer Early. Here’s How.

When the Forward first wrote about Harvey Singer two years ago, he shared his trials of being diagnosed with breast cancer in 2008. The Rochester, New York, resident opted for a full mastectomy, only to be diagnosed with prostate cancer 18 months later. Recently, we learned that Singer faced yet another monumental health scare after we spoke with him in 2014.

Singer recalls that after taking several prostate-specific antigen (PSA) blood tests, which is the standard way to detect prostate cancer, he noted that his test results were steadily rising. Although a PSA test alone cannot confirm evidence of cancer, the higher a man’s PSA level, the more likely it is that he has prostate cancer, according to the National Cancer Institute. Moreover, a continuous rise in a man’s PSA level over time may also be a sign of prostate cancer.

“What should have been 0.0 was 0.01, 0.02, then 0.04 and 0.07,” recalled Singer, 62, of the test results.

Singer’s oncologist wanted to follow the standard protocol, which uses a PSA level of 0.2 as an indication that the cancer had returned, but Singer refused to sit on his hands. He had received genetic testing after his original prostate cancer diagnosis and found he was a BRCA2 carrier, which placed him at increased risk for an aggressive form of the disease.

Singer opted for 39 grueling treatments of radiation, and his PSA ultimately returned to an undetectable level a year and a half later. He is vigilant about monitoring for disease and continues to have blood tests every three months.

“What I tend to shout from the rooftops is that if you’re going through any of this cancer stuff, you have to be your own advocate,” Singer said.

He and his sister, Vicki, who is a three-time breast cancer survivor and also carries the BRCA2 defect, co-founded HIS Breast Cancer Awareness Foundation to fill the information void about the risk for men with BRCA mutations. Singer also shared his story in a book and recent film “Pink and Blue: Colors of Hereditary Cancer,” a documentary about male mutation carriers.

“You ask 20 guys if they carry the BRCA gene, probably 18 will tell you no because they don’t understand,” said Singer. “They think, oh, it’s a women’s genetic disposition, it’s not something for a man,” he added.

Karen Iris Tucker is a freelance journalist who writes primarily about health, genetics and cultural politics. Finder her work at kareniristucker.com and on Twitter @kareniristucker

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse..

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.